Just published data from a phase 3 trial confirm that cemiplimab improves survival in patients with recurrent cervical cancer, as this indication awaits FDA approval.
Medscape Medical News
…read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
